SelectQuote to Detail Tech Strategy at Mizuho Amid Market Headwinds

OVERLAND PARK, Kan. – February 26, 2026 – SelectQuote, Inc. (NYSE: SLQT) is set to outline its strategic vision to the investment community next week as its top executives participate in Mizuho’s 2026 Virtual Healthcare Technology Conference. The March 5 event provides a critical platform for the company to articulate its evolution from an insurance brokerage pioneer to an integrated, technology-driven healthcare services provider.

Chief Executive Officer Tim Danker and Chief Financial Officer Ryan Clement will engage in one-on-one and small group meetings with investors. The discussions come at a pivotal moment for the company, which is navigating a complex industry landscape marked by both significant growth opportunities in its newer segments and persistent profitability challenges.

A Strategic Pitch to Investors

Investors will be listening closely as SelectQuote’s leadership presents their case. The company recently posted strong fiscal second-quarter results for 2026, beating analyst estimates with consolidated revenue of $537.1 million and net income of $69.3 million. This performance, reported on February 5, offered a positive signal after a more challenging start to the fiscal year.

The first quarter saw consolidated revenue grow 13% year-over-year to $329 million, but the company reported a negative Adjusted EBITDA of $(32) million. The shortfall was attributed primarily to margin pressures within its rapidly growing SelectRx pharmacy division. These pressures, described as “PBM reimbursement headwinds,” have been a recurring theme and prompted the company to adjust its full-year outlook for the Healthcare Services segment.

For the full fiscal year 2026, SelectQuote now projects revenue between $1.61 billion and $1.71 billion, with Adjusted EBITDA in the range of $90 million to $100 million. This revised guidance, down from earlier projections, reflects the impact of the pharmacy reimbursement dynamics and a significant marketing budget cut by a national carrier partner. Consequently, management’s narrative at the Mizuho conference will be crucial for rebuilding investor confidence in its long-term earnings power.

Analyst sentiment currently reflects this wait-and-see approach, with a consensus “Hold” rating on the stock. However, average price targets hover around $2.88, suggesting that Wall Street sees substantial potential upside if the company can successfully execute its strategy and overcome the current headwinds.

Beyond Brokerage: The Healthcare Services Engine

At the heart of SelectQuote’s story is its strategic diversification beyond its foundational insurance distribution model. The company's fast-growing Healthcare Services platform, which will undoubtedly be a focus at the tech-centric conference, is comprised of three key pillars: SelectRx Pharmacy, SelectPatient Management, and Healthcare Select.

SelectRx, a PCPH-accredited pharmacy, has been the primary engine of growth. Acquired in 2021, the service has expanded from under 5,000 to over 75,000 members by late 2024. It aims to improve health outcomes by simplifying medication management, delivering pre-packaged doses directly to members’ homes. Trials have shown this model boosts medication adherence to over 90%, a key metric for improving HEDIS Star ratings for insurance partners. To support this explosive growth, a new 54,000-square-foot fulfillment center in Kansas is expected to come online in 2025. While revenue in the segment has surged—up 26% year-over-year in the most recent quarter—profitability has been squeezed by pharmacy benefit manager (PBM) reimbursement rates. A new multiyear PBM agreement announced in January is expected to provide greater pricing visibility, a point management will likely emphasize to investors.

Complementing the pharmacy are Healthcare Select, a service connecting Medicare beneficiaries with resources for chronic care and social determinants of health, and SelectPatient Management, which provides chronic care management services. Together, these components form an integrated ecosystem designed to engage consumers across insurance, pharmacy, and virtual care, positioning the company as a player in the value-based care movement.

This technology-enabled platform is SelectQuote's primary differentiator. By leveraging its customer acquisition expertise to funnel members into these higher-touch services, the company aims to create more value for patients and payer partners, moving beyond the transactional nature of policy sales.

Navigating a Turbulent Healthcare Landscape

SelectQuote’s strategic shift is occurring against the backdrop of a volatile and rapidly evolving healthcare market. The 2026 Medicare Advantage (MA) landscape has been roiled by disruption. Major insurers like UnitedHealthcare and Centene have pulled back from certain markets, citing rising medical costs and regulatory pressures. This has forced nearly 2.7 million beneficiaries to find new plans, creating a significant opportunity for skilled brokers like SelectQuote to guide consumers through the confusion.

Simultaneously, the market is seeing a pronounced shift towards Special Needs Plans (SNPs) that cater to individuals with chronic conditions or dual eligibility, an area where SelectQuote’s integrated care model could prove particularly advantageous. In this environment, the company’s ability to offer more than just a policy—providing tangible healthcare services through SelectRx and its other platforms—becomes a powerful competitive advantage.

The competitive field is crowded and diverse. In its core business, SelectQuote competes with other large brokers and insurance carriers. In its newer ventures, it faces a different set of rivals, from digital pharmacy giants like Amazon and Alto Pharmacy to a burgeoning field of digital health and value-based care startups. Furthermore, significant regulatory changes, including a new cap on Medicare Part D out-of-pocket costs and expanded coverage for certain drugs, are reshaping the financial models for everyone in the industry. The Mizuho conference gives SelectQuote’s leadership a forum to articulate how its unique, hybrid model is purpose-built to thrive amidst this complexity, capturing value from both the disruption in insurance distribution and the systemic shift towards integrated, technology-driven healthcare.